Chan-Mi Park

Title: Innovations of Chan-Mi Park in Tubulin Polymerization Inhibition

Introduction

Chan-Mi Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioscience and biotechnology, particularly in the development of novel compounds that can serve as anticancer agents. His work focuses on inhibiting tubulin polymerization, which is crucial for cell division.

Latest Patents

One of Chan-Mi Park's key patents is titled "Tubulin polymerization inhibitor and method for synthesizing same." This invention relates to the compound (E)-ethyl 2-(2-methyl-3-((2-(naphtho[2,1-b]furan-2-carbonyl)hydrazono)methyl)-1H-indol-1-yl)acetate. This compound has the ability to inhibit mitosis and induce apoptosis, making it a potential anticancer agent. The method for synthesizing this compound is efficient, achieving a yield of 60% or higher, which simplifies the reaction process.

Career Highlights

Chan-Mi Park is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work has been instrumental in advancing research in cancer treatment through innovative chemical synthesis and compound development.

Collaborations

He has collaborated with notable colleagues, including Nak Kyun Soung and Bo Yeon Kim, to further enhance the research and development of his inventions.

Conclusion

Chan-Mi Park's contributions to the field of bioscience through his innovative patent on tubulin polymerization inhibitors highlight the importance of research in developing effective cancer treatments. His work exemplifies the intersection of science and innovation in addressing critical health challenges.